Monday 16 December 2019
Home      All news      Contact us     
Reuters - 30 days ago

CORRECTED-UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval

Novartis AG on Friday won U.S. approval for its experimental sickle cell disease drug, Adakveo, making it the first of several proposed new therapies designed to offer lasting relief for patients with the debilitating blood disease to get U.S. regulatory clearance.

Related news

Latest News
Hashtags:   

CORRECTED

 | 

UPDATE

 | 

Novartis

 | 

sickle

 | 

approval

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources